Introduction
Atypical benign partial epilepsy (ABPE) of childhood was described by Aicardi and Chevrie. 1 The onset of seizures occurs between 2 and 7 years of age. A period of typical rolandic seizures is followed by frequent atonic seizures, partial or generalized, that lead to frequent falls. These seizures were later termed ''negative myoclonus of the lower limbs''. 2 In addition to seizures characterized by falls, other types of seizures such as partial and generalized motor seizures as well as atypical absence seizures also occur.
1,2
The electroencephalogram (EEG) shows typical bilateral rolandic spikes and spike-wave activity during sleep. Based on these characteristics, ABPE has been considered to be a ''classic'' atypical variant of benign childhood epilepsy with centrotemporal spikes (BECT). Seizure prognosis in ABPE may be resistant to treatment. In the previous study of 43 patients with ABPE, 7 patients (16%) were not seizure-free at the end of the study. 6 Their ages ranged from 5 to 13 years. Furthermore, cognitive problems and mental retardation have frequently been noted. 6 Giant middle-latency somatosensory evoked potentials (giant SEPs) have been reported in subjects with BECT. The giant SEPs in those patients have been interpreted as a consequence of an excitable sensorimotor cortex. 3, 7 However, action myoclonus with giant SEPs has not been previously reported in cases of ABPE or other types of benign childhood epilepsy. We describe a boy with rolandic seizures accompanied by clusters of atypical absence seizures; the EEG of the latter corresponded to those associated with ABPE. Of note, he suffered from developmental delay beginning in infancy and experienced giant SEPs with action myoclonus.
Case report
This boy was born uneventfully after 38 weeks of pregnancy. At the age of 10 months, tremor was observed in the extremities during wakefulness. Zonisamide and clonazepam were started because epileptic discharges were observed in bilateral frontal areas; this treatment did not affect the tremor. A GC-MS analysis of the urine showed no abnormalities.
At the age of 1 year and 4 months, he was referred to our hospital for rehabilitation due to developmental delay. On examination, he had normal facial appearance and mild hypotonia. His tremor increased at voluntary movements, which was considered to be action myoclonus because a surface electromyogram (EMG) showed We describe a boy, 3 years and 6 months old, who experienced a rolandic seizure accompanied by a cluster of atypical absence seizures, the EEGs for which corresponded to those of atypical benign partial epilepsy (ABPE). Of note, this patient suffered from developmental delay beginning in infancy and exhibited giant middle-latency somatosensory evoked potentials with action myoclonus. With the exceptions of ethosuximide, acetazolamide, and adrenocorticotropic hormone, which have been reported to be effective in ABPE, the atypical absence seizures were intractable despite extensive treatment with various anticonvulsants. The drugs that were effective led to a remarkable reduction in seizure frequency and EEG improvement, but the efficacy was temporary. The patient demonstrated moderate mental retardation without regression and could not walk with support or speak any meaningful words at the age of 3 years and 6 months. Based on thorough differential diagnosis, although further studies will be necessary, we propose that this boy may present a new phenotype of ABPE: ABPE with action myoclonus.
ß 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved. Rhythmic co-contraction of the right biceps and triceps muscles, which was not accompanied by epileptic discharges, were observed at a rate of 5 Hz. (B) At the age of 1 year and 8 months, frequent bilateral centrotemporal sharp waves or spikes and waves were recorded and exhibited left-side predominance (sleep record). (C) At the age of 2 years and 6 months, diffuse spikeand-wave complexes were recorded, with maximum accentuation over both centrotemporal regions (awake record). (D) At the age of 2 years and 9 months, motionless arrests for a few seconds (arrows) were frequently observed; these corresponded to almost continuous diffuse spike-and-wave complexes with left-side predominance, which were considered to be clusters of atypical absence seizures (awake record). (E) Diffuse spike-and-wave complexes vanished 1 week after starting ACTH. The artifacts of teeth grinding were seen in the left temporal area (awake record).
rhythmic discharges with duration of 20-30 ms on the acting and antagonistic muscles without any corresponding epileptic discharges (Fig. 1A) . His myoclonus was exclusively intensified by voluntary movements. By contrast, it was not increased at rest or posture, or sound stimulation. Interictal EEG showed sharp waves or spikes in the right or left centrotemporal areas, independently (Fig. 1B) . No seizures, including focal ones, were observed at that time. Magnetic resonance imaging (MRI) of the brain and ophthalmological findings were normal. Giant SEPs were detected on median nerve stimulation ( Fig. 2A) , which suggested that the myoclonus was generated from the cerebral cortex. C-reflex was not recognized. Piracetam was not effective for his myoclonic movements. At the age of 2 years and 5 months, this patient could not walk with support due to action myoclonus of the legs. His developmental quotient was 40, as measured with the Enjoji Developmental Scale. The simultaneous video-EEG monitoring detected atypical absence seizures, during which he demonstrated motionless arrest for a few seconds corresponding to diffuse 2.5-to 3.5-Hz spike-and-wave bursts that were dominant in the right or left centrotemporal areas (Fig. 1C) . Focal hemifacial seizures and generalized tonic-clonic seizures were also observed on several occasions. However, negative myoclonus was not observed. Therefore, his epilepsy was characterized by a coexistence of rolandic seizures and atypical absence seizures associated with action myoclonus and giant SEPs.
Because we diagnosed this patient with a condition that mimics ABPE, we added ethosuximide (ESM) (20-30 mg/kg/day), which resulted in the complete disappearance of atypical absence seizures (Fig. 2B) . Two months later, however, atypical absence seizures recurred in the form of a cluster of seizures (Fig. 1D) . The spike-wave index during non-REM sleep rose up to 80%. 10-12-Hz a-waves bursts also appeared in the right or left centrotemporal areas during sleep. Developmental regression was not observed, despite frequent atypical absence seizures. Various anticonvulsants were not effective (Fig. 2B 1) . At that time, tandem mass spectrometry, amino acid analysis, fluorescence in situ hybridization (FISH) and methylation analysis of Angelman syndrome, sequencing of the UBE3A gene and DNA analysis of DRPLA and MERRF, were performed; all results were normal. The blood and cerebral spinal fluid levels of lactate and pyruvate were normal. Bone marrow examination for foam cells, sea blue histiocytes, or vacuolated lymphocytes were all negative. Eight lysosomal enzyme activities were all normal. Pepinase activity and palmitoyl-protein thioesterase activity assays ruled out infantile neuronal ceroid lipofuscinosis. A CGH array analysis (Agilent 60K) showed no abnormality. ECD-SPECT and FDG-PET showed no remarkable findings.
Synthetic adrenocorticotropic hormone (ACTH) therapy at 0.015 mg (0.6 IU)/kg/day for 2 weeks followed by a half-dose of alternate-day use for 2 weeks was dramatically effective. His atypical absence seizures and action myoclonus completely vanished 4 days after starting ACTH (Fig. 1E) . However, 1 month later, clusters of atypical absence seizures re-appeared. Acetazolamide (AZA) (20 mg/kg/day) was also temporally effective. At the age of 3 years and 6 months, the second trial of ACTH resulted in the disappearance of atypical absence seizures and focal seizures. The patient demonstrated moderate mental retardation without regression. He also had hypostature (À2.9SD). The repeat MRI with 3 Tesla showed no brain atrophy or focal cortical dysplasia.
Discussion
In our patient clinical seizures and his EEG data were similar to those associated with ABPE, with the exception of the absence of negative myoclonus. Our patient may be considered the severe end of a spectrum of cognitive problems associated with an atypical variant of benign childhood epilepsy. Electrical status epilepticus in sleep, one of the atypical evolutions of benign childhood epilepsy with centrotemporal spikes, 12 may be listed in the differential diagnosis for this patient. However, we believe that this is less likely because of the absence of regression in cognitive functions and the status of absence seizures as a cardinal type of seizure. Cortical myoclonus originating from abnormal electrical activity in the cerebral cortex is stimulus-sensitive or action-induced myoclonus, which is often associated with giant SEPs. 8 Cortical myoclonus has been most extensively studied in progressive myoclonus epilepsy. Other childhood diseases such as Lance-Adams syndrome, metabolic encephalopathy, Rett syndrome, Angelman syndrome, and celiac disease are also reported to include cortical myoclonus. 11 However, we excluded these diseases based on examinations or clinical neurological findings. The patient's seizures were very intractable and resistant to the various antiepileptic drugs. However, ESM, AZA, and ACTH, which have been reported to be effective in ABPE, led to a definite reduction in seizure frequency and to improved EEG results, 4, 9 although most of those effects were temporary. The existence of action myoclonus and the response to the aforementioned drugs suggested that type I focal cortical dysplasia was not possible. ESM is considered to block T-type Ca 2+ current by inhibiting T-type Ca 2+ channels in thalamic neurons, leading to the suppression of epileptic seizures. 5 Furthermore, Richards et al. demonstrated that the target of the ESM effect on absence seizures was not only thalamic nuclei but also the corresponding cortex. 10 Therefore, the dramatic impact of ESM in patients with ABPE may be explained by the unique antiepileptic effect of ESM on both the thalamus and sensorimotor cortex. The temporary, but nonetheless evident, effects of ESM in this case imply that the epileptic networks in our patient were closely associated with those for ABPE. On the other hand, clinical symptoms of ABPE, in this case, may be associated with the undiagnosed encephalopathy characterized by action myoclonus. No gross lesion was seen on MRI, and the diagnostic evaluations have not detected any abnormality, but careful further follow up is necessary, as such undiagnosed encephalopathy may still become evident with time. In conclusion, as seen in our case, action myoclonus may be seen accompanying ABPE; further studies will be necessary to confirm the association in these cases with co-existing action myoclonus and ABPE.
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